Benitec Biopharma - Stock Price History | BNTC

Historical daily share price chart and data for Benitec Biopharma since 2022 adjusted for splits. The latest closing stock price for Benitec Biopharma as of December 02, 2022 is 0.19.
  • The all-time high Benitec Biopharma stock closing price was 83.90 on August 20, 2015.
  • The Benitec Biopharma 52-week high stock price is 3.30, which is 1636.8% above the current share price.
  • The Benitec Biopharma 52-week low stock price is 0.13, which is 31.6% below the current share price.
  • The average Benitec Biopharma stock price for the last 52 weeks is 1.38.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Benitec Biopharma Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 3.9338 3.3400 9.2600 2.5900 2.6200 -12.67%
2020 5.5583 4.6500 14.1700 2.6100 3.0000 -41.18%
2019 11.3174 15.0000 21.9000 4.2300 5.1000 -66.00%
2018 27.0114 29.1000 39.6000 11.4510 15.0000 -49.32%
2017 24.2472 15.3000 41.0000 15.3000 29.6000 93.46%
2016 18.8566 41.9000 42.6960 12.0000 15.3000 -61.94%
2015 60.3624 79.7000 83.9000 39.9000 40.2000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.005B $0.000B
Benitec Biopharma Limited is a biotechnology company which developed a patented gene silencing technology delivered by gene therapy called DNA directed RNA interference. The company is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including hepatitis C and B, drug resistant lung cancer and wet age-related macular degeneration. Benitec Biopharma Limited is based in Sydney, Australia.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $172.495B 10.52
GSK (GSK) United Kingdom $71.890B 9.01
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.433B 19.52
Ginkgo Bioworks Holdings (DNA) United States $3.861B 0.00
Myovant Sciences (MYOV) United Kingdom $2.605B 0.00
Arcus Biosciences (RCUS) United States $2.586B 38.81
Biohaven (BHVN) United States $1.141B 0.00
Emergent Biosolutions (EBS) United States $0.599B 4.71
Zymeworks (ZYME) Canada $0.478B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.278B 0.00
Enzo Biochem (ENZ) United States $0.096B 0.00
SQZ Biotechnologies (SQZ) United States $0.046B 0.00
Gelesis Holdings (GLS) United States $0.035B 0.00
Ambrx Biopharma (AMAM) United States $0.019B 0.00